The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG

Deutsche Bank Deutsche Bank AG, Hong Kong Branch Level 60 International Commerce Centre 1 Austin Road West Kowloon, Hong Kong SAR 17 August 2026 1. Department of Corporate Services, BSE Limited Floor 25, P J Towers, Dalal Street, Mumbai - 400 001 2. National Stock Exchange of lndia Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 3. CC: Piramal Pharma Limited Ground Floor, Piramal Ananta, Agastya Corporate Park, Kamani Junction, LBS Marg, Kurla (West), Mumbai, Maharashtra – 400070 Sub: Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dear Sir/Ma’am, We write in our capacity as pledgee for the Pledged Shares (as defined below) of Piramal Pharma Limited pledged in our favour by CA Alchemy Investments. Enclosed is a disclosure by Deutsche Bank AG, Mumbai Branch (“Onshore Security Agent”) under Regulation 29 (2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the “Takeover Code”). This disclosure is in addition to our disclosure dated 30 May 2024 under Regulation 29(2) of the Takeover Code (“Earlier Disclosure”). In the Earlier Disclosure, we Deutsche Bank AG, Mumbai Branch acting in our capacity as the onshore security agent in respect of the Facility (as defined in the Earlier Disclosure), made a disclosure in respect of the encumbrance by way of pledge over the 238,663,700 equity shares of the issued and paid-up share capital of Piramal Pharma Limited (“Target Company”) constituting 17.93% of the issued and paid-up share capital (on a fully diluted basis) and 18.01% of the total voting capital of the Target Company. Pursuant to clause 23.7(c) (Disposals) of the Facility Agreement (as defined in the Earlier Disclosure), the Borrower proposes to undertake a ‘Permitted Sale Transaction’ (as defined in the Facility Agreement). Accordingly, the Onshore Security Agent has released 98,400,000 equity Chairman of the Supervisory Board: Alexander R. Wynaendts Management Board: Christian Sewing (Chairman), James von Moltke, Fabrizio Campelli, Marcus Chromik, Bernd Leukert, Alexander von zur Mühlen, Laura Padovani, Claudio de Sanctis, Rebecca Short Deutsche Bank Aktiengesellschaft domiciled in Frankfurt am Main; Local Court of Frankfurt am Main, HRB No 30 000; VAT ID No DE114103379; www.db.com Deutsche Bank shares of the issued and paid-up share capital of the Target Company, constituting 7.39% of the total issued and paid-up share capital of the Target Company (on a fully diluted basis) and 7.43% of the total voting capital of the Target Company (“Released Shares”). After such release, the Onshore Security Agent continues to hold a pledge over 140,263,700 equity shares of the issued and paid- up share capital of the Target Company constituting 10.54 % of the issued and paid-up share capital (on a fully diluted basis) and 10.59% of the total voting capital of the Target Company (“Pledged Shares”). This disclosure is being made by the Onshore Security Agent in respect of release of encumbrance over the Released Shares. We also wish to clarify that as at the date of this disclosure, we do not hold any beneficial interest in the Pledged Shares and the Pledged Shares have been pledged in our favour in our capacity as pledgee. We request you to take the same on record and acknowledge the same. Signature of Authorised Signatory Name: RAMANATHAPURA, Prasanna Venkatesha Murthy Manu Designation: Vice President Place: Deutsche Bank AG, Hong Kong Branch Date: 17 August 2026 Chairman of the Supervisory Board: Alexander R. Wynaendts Management Board: Christian Sewing (Chairman), James von Moltke, Fabrizio Campelli, Marcus Chromik, Bernd Leukert, Alexander von zur Mühlen, Laura Padovani, Claudio de Sanctis, Rebecca Short Deutsche Bank Aktiengesellschaft domiciled in Frankfurt am Main; Local Court of Frankfurt am Main, HRB No 30 000; VAT ID No DE114103379; www.db.com Disclosure under Regulation 29(2) of SEBl (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company Piramal Pharma Limited (TC) Name(s) of the acquirer and Deutsche Bank AG, Mumbai Branch acting in its capacity as Persons Acting in Concert (PAC) the onshore security agent for Lenders (as defined in the with the acquirer Earlier Disclosure) to CA Alchemy Investments under the Facility Agreement (as defined in the Earlier Disclosure) Deutsche Bank AG, Singapore Branch DBX Advisors LLC Whether the acquirer belongs to No Promoter/Promoter group Name(s) of the Stock BSE Limited and National Stock Exchange of India Limited Exchange(s) where the shares of TC are Listed % w .r.t. total % w.r.t. total diluted share/voting Details of the acquisition as share/voting Number capital follows capital of the wherever applicable(*) (**) Before the acquisition under 1,317 0.00% of 0.00% of consideration, holding of: total total share capital share capital / 0.00% of / 0.00% of (a) Shares carrying voting voting capital voting capital rights # # (b) Shares in the nature of 238,663,700# 17.93% of 17.93% of encumbrance (pledge/ total total lien/ non-disposal share capital share capital undertaking/ others) / 18.01% of / 18.01% of voting capital voting capital (c) Voting rights (VR) Nil Nil Nil otherwise than by shares (d) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) (e) Total (a+b+c+d) 238,665,017# 17.93% of 17.93% of total total share capital share capital / 18.01% of / 18.01% of voting capital voting capital Details of acquisition Nil Nil Nil (a) Shares carrying voting rights acquired / sold (b) VRs acquired otherwise Nil Nil Nil than by shares (c) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/ sold (d) Shares encumbered/ 98,400,000# 7.39% of 7.39% of invoked/ released by the total total acquirer (See Note #) share capital share capital / 7.43% of / 7.43% of voting capital voting capital (e) Total (a+b+c+/-d) 98,400,000# 7.39% of 7.39% of total total share capital share capital / 7.43% of / 7.43% of voting capital voting capital After the acquisition/ sale, 1,317 0.00% of 0.00% of holding of: total total share capital share capital (a) Shares carrying voting / 0.00% of / 0.00% of rights voting capital voting capital (b) Shares encumbered with the 238,663,700# 17.93% of 17.93% of acquirer total total share capital share capital / 18.01% of / 18.01% of voting capital voting capital (b) VRs otherwise than by Nil Nil Nil shares (c) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition (d) Total (a+b+c+d) 238,665,017# 17.93% of 17.93% of total total share capital share capital / 18.01% of / 18.01% of voting capital voting capital Mode of acquisition (e.g. open Release of encumbrance. Please see note # below. market/ off-market/public issue/rights issue/preferential allotment/inter se transfer/ etc.) Date of acquisition/ sale of shares 13 August 2026 (date of release of encumbrance) / VR or date of receipt of intimation of allotment of shares, whichever is applicable. Equity share capital / total voting 1,331,348,130 shares/ 1,325,018,448 voting shares of INR capital of the TC before the said 10 each acquisition / sale Equity share capital/ total voting 1,331,348,130 shares/ 1,325,018,448 voting shares of INR capital of the TC after the said 10 each acquisition / sale Total diluted share/voting capital 1,331,348,130 shares/ 1,325,018,448 voting shares of INR of the TC after the said acquisition 10 each Note-# 1. This disclosure is in addition to our disclosure dated 30 May 2024 under Regulation 29(2) [Showing first 8,000 characters — download PDF for full document]